Steffen P, Krell M, Seeling W
Schmerzambulanz, Universitätsklinik für Anästhesiologie Ulm.
Schmerz. 2004 Aug;18(4):278-85. doi: 10.1007/s00482-003-0304-0.
The purpose of this study was to evaluate the analgesic efficacy of 25 mg rofecoxib.
In a randomized, prospective double-blind study we investigated the analgesic efficacy of 25 mg rofecoxib in 62 patients scheduled for minor trauma surgery. Patients received 2 h before induction of anesthesia either 25 mg rofecoxib (verum) orally or placebo. These applications were repeated postoperatively after 24 h. Postoperative pain intensity was measured by the numeric rating scale (NRS). All patients were allowed to order piritramid from a PCA-device (bolus 2 mg, lockout 5 min in the recovery room, 15 min on the ward) for 24 h after surgery. 10/20/30 min, as well as 1/2/4/6 h and 24 h after surgery cumulated doses of piritramid, pain scores (0-10) and side effects were recorded.
Pain relief and cumulated doses of piritramid in both groups were comparable at all points in time. There were no significant differences in the incidence of side effects between the two groups.
Preoperative application of 25 mg rofecoxib is not effective for postoperative analgesia in patients after minor trauma surgery.
本研究旨在评估25毫克罗非昔布的镇痛效果。
在一项随机、前瞻性双盲研究中,我们调查了25毫克罗非昔布对62例计划进行小型创伤手术患者的镇痛效果。患者在麻醉诱导前2小时口服25毫克罗非昔布(试验组)或安慰剂。术后24小时重复给药。术后疼痛强度通过数字评分量表(NRS)进行测量。所有患者术后24小时内可从PCA装置(负荷剂量2毫克,恢复室锁定时间5分钟,病房锁定时间15分钟)按需使用匹米诺定。记录术后10/20/30分钟、1/2/4/6小时及24小时时匹米诺定的累积剂量、疼痛评分(0-10分)及副作用。
两组在所有时间点的疼痛缓解情况及匹米诺定累积剂量均相当。两组副作用发生率无显著差异。
术前应用25毫克罗非昔布对小型创伤手术后患者的术后镇痛无效。